SAS Output

18-JUN-2019 6:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 Y 1 Recurrence Score testing 9400 9383 0 0 0 0 0 02/28/2011 307 160
            9383 0 0 0 0 0      
 
    2 Y 2 Chemo and Endocrine Therapy 5000 2547 0 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   2536 0 0 0 0 0      
            5083 0 0 0 0 0      
 
  S1222-Brst,Fulv. +/- Ever. +/- Anastr. 1 T 1 Blinded treatment 840 12 0 0 0 0 0 05/15/2014 8 1
        2 Blinded treatment   12 0 0 0 0 0      
        3 Blinded treatment   13 0 0 0 0 0      
            37 0 0 0 0 0      
 
  S1416-Brst, TNBC/BRCA, Cis+/- ABT-888 1 Y 1 Blinded Drug + Cisplatin 333 170 47 31 14 3 0 09/15/2016 259 114
        2 Blinded Drug + Cisplatin   174 53 32 15 3 1      
            344 100 63 29 6 1      
 
  S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 Y 1 Tissue for PD-L1 testing 1000 579 337 190 102 33 10 01/18/2017 478 210
            579 337 190 102 33 10      
 
    2 Y 2 Observation 1000 246 140 87 46 12 3 01/18/2017    
        3 MK-3475 (Pembrolizumab)   242 140 81 42 14 2      
            488 280 168 88 26 5      
 
  S1706-Breast, Inflammatory, RT +/- Olaparib 1 Y 1 Olaparib + RT 300 5 5 5 4 1 0 01/18/2019 143 66
        2 RT   3 3 3 2 0 0      
            8 8 8 6 1 0      
 
Yes A011106-Breast, Neoadj, ALTERNATE study 1 E Total Registrations   94 35 14 7 0 0 04/29/2014   128
            94 35 14 7 0 0      
 
  E1Z11-Brst,Genetic Predictors of AIMSS 1 E Total Registrations   156 6 0 0 0 0 08/13/2013    
            156 6 0 0 0 0      
 
  NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo 1 E Total Registrations   74 18 7 5 1 0 10/16/2015   168
            74 18 7 5 1 0      
 
  NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv 1 E Total Registrations   7 7 1 1 0 0 06/22/2018 160 81
            7 7 1 1 0 0      
 
No A011401-Breast, adj, Stage II/III HER2-, weight loss 1 E Total Registrations   243 96 48 26 6 0 10/05/2016   251
            243 96 48 26 6 0      
 
    2 E Total Registrations   223 92 44 25 5 0 10/05/2016    
            223 92 44 25 5 0      
 
  A011502-Brst, Adj, Nodal+&HER2-, Aspirin vs. Placebo 1 E Total Registrations   107 61 42 26 9 4 03/20/2017 363 207
            107 61 42 26 9 4      
 
  A221405-Breast, ET interruption, Pregnancy Outcomes 1 E Total Registrations   18 9 5 5 0 0 05/08/2017 128 51
            18 9 5 5 0 0      
 
  B51-Breast, Regional Nodal XRT 1 E Total Registrations   34 7 1 0 0 0 06/13/2014   157
            34 7 1 0 0 0      
 
  B55-Brst, Adj Olaparib for BRCA,TNBC 1 E Total Registrations   72 13 4 2 0 0 12/15/2014 327 141
            72 13 4 2 0 0      
 
    2 E Total Registrations   34 8 2 1 0 0 12/15/2014    
            34 8 2 1 0 0      
 
  EA1131-Brst, TNBC, Post-op Chemo vs Obs 0 E Total Registrations   30 12 7 3 1 0 11/12/2015   122
            30 12 7 3 1 0      
 
    1 E Total Registrations   16 5 4 0 0 0 11/12/2015    
            16 5 4 0 0 0      
 
  EA1151-Brst, Tomosynthesis Mammographic Screening 1 E Total Registrations   472 364 215 129 45 11 01/30/2018 154 76
            472 364 215 129 45 11      
 
  NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA 1 E Total Registrations   1 0 0 0 0 0 09/22/2017 258 114
            1 0 0 0 0 0